Association of IGF-1 CA(n) and IGFBP3 rs2854746 Polymorphisms with Endometrial Polyp Risk

Table 5

Multivariate logistic regression between the IGF-1 CA(n) and IGFBP3 rs2854746 polymorphisms adjusted for hypertension, age range, and hormone replacement therapy (HRT) use.

	OR	95 C.I.	P-Value
HRT
não	1
Sim	0,2462	(0,096-0,631)	0,003
Arterial hypertension
não	1
sim	0,8201	(0,341-1,968)	0,657
Age range
29-39	1
40-49	0,2012	(0,042-0,946)	0,042
50-59	0,0326	(0,007-0,143)	0,005
60-80	0,1387	(0,029-0,647)	0,012
IGF-1 CA(19)
CA(<19)/CA(n)	1
CA(19)/CA(19) + CA(>19)/CA(n)	3,7191	(1,380-10,020)	0,009
IGFBP3
CC	1
CG	0,1607	(0,063-0,409)	0,001
GG	0,6648	(0,192-2,298)	0,518